Plant-Derived Compound
L-arabinose occurs naturally in plant materials. The published toxicological evaluation of Sukré describes it as a purified form obtained from hydrolysed acacia.
Sukré is described as a prebiotic sweetener. Discover what is known about its identified L-arabinose component, how it has been studied and why careful interpretation of the evidence matters.
Explore SukréSukré™ is a branded ingredient developed by Compound Solutions and described by its manufacturer as a naturally sweet prebiotic. It is intended for use in functional foods, beverages and other food applications.
A scientific toxicology publication identifies Sukré™ as highly purified L-arabinose produced from hydrolysed acacia. L-arabinose is a naturally occurring plant-derived sugar that has attracted research interest because of its interaction with the digestion of sucrose, the common sugar found in many foods and drinks.
This distinction is important. The name Sukré refers to a particular branded ingredient, while L-arabinose is the compound identified in the published toxicological evaluation. Research on L-arabinose can help explain why the ingredient is being studied, but results from studies using other preparations do not automatically establish the effects of every branded product or finished supplement.
Understanding the ingredient therefore starts with its identity, how it may interact with digestion and what human research has actually measured.
L-arabinose is a plant-derived monosaccharide found as part of the structure of certain plant materials. Researchers have investigated its possible influence on the digestion of sucrose.
L-arabinose occurs naturally in plant materials. The published toxicological evaluation of Sukré describes it as a purified form obtained from hydrolysed acacia.
Research suggests that L-arabinose can inhibit sucrase, an intestinal enzyme involved in breaking sucrose into glucose and fructose during digestion.
Some small human studies have examined L-arabinose and post-meal glucose responses. However, findings depend on the food tested, the amount used and the participants involved.
Sucrose is the familiar table sugar found in many sweet foods and drinks. During digestion, an enzyme called sucrase helps split sucrose into two simpler sugars: glucose and fructose.
L-arabinose has been studied for its ability to inhibit sucrase activity. By interfering with this enzyme, it may slow the breakdown of sucrose and change the timing of glucose absorption after a sucrose-containing food or drink.
This is a digestive mechanism, not evidence that the ingredient switches off glucose production, activates fat burning or changes how the body stores all dietary energy.
It is also important to distinguish sucrose from other carbohydrates. A finding involving a sugary drink does not necessarily apply to every meal, particularly meals containing starch, fibre, protein and fat.
Several human studies have investigated L-arabinose in combination with sucrose. Their findings offer useful information, but they should be interpreted within the limits of each study.
A small randomised crossover study involving 12 healthy adults examined a drink containing sucrose with or without L-arabinose. The researchers found that adding L-arabinose delayed the rise in blood glucose and reduced the early glucose peak.
A 2025 crossover trial involving 18 older adults with impaired fasting glucose found that a single sucrose drink containing L-arabinose produced lower glucose and insulin peaks than the comparison drink.
Not all studies have found the same effect. Research involving mixed meals has reported that L-arabinose did not consistently change glucose or insulin responses, highlighting the importance of food composition.
Results from a controlled drink test cannot automatically be applied to everyday eating patterns, people with different health conditions or long-term blood glucose management.
Much of the available research focuses on glucose and insulin responses over a few hours after consumption. These measurements do not establish long-term changes in HbA1c, diabetes risk or overall metabolic health.
Larger and longer human studies are needed to clarify the effects of L-arabinose preparations, including branded Sukré, across different foods, doses and population groups.
The body's use and storage of energy is a complex process involving hormones, organs, muscles, dietary intake and overall energy balance. Glucose can be used directly by cells, stored as glycogen or contribute to other metabolic processes depending on the body's needs.
Because L-arabinose has been studied for its effect on sucrose digestion, it may influence the timing of glucose absorption under certain test conditions. However, this does not demonstrate that Sukré prevents the body from storing fat or causes it to burn stored fat instead.
A change in a short-term glucose response is not the same as a change in body composition. Demonstrating an effect on fat mass would require appropriate human trials that directly measure body composition over time.
At present, the available evidence does not establish that Sukré reduces body fat, reverses insulin resistance or produces lasting weight loss. These outcomes should not be assumed from research on sucrose digestion alone.
A prebiotic is generally understood as a substance used by microorganisms in the body that can provide a health benefit. Certain dietary fibres and other compounds can be selectively utilised by gut microorganisms.
The manufacturer describes Sukré as a prebiotic sweetener and promotes it for functional food and digestive health applications. However, a product description is not the same as proof of a specific health outcome in human trials.
Research on acacia fibre and other prebiotic ingredients cannot automatically be used to establish the effects of purified L-arabinose. These substances have different structures and may behave differently in the digestive system.
To understand the prebiotic potential of Sukré more fully, further research would need to examine its effects on the human gut microbiome, digestive function and meaningful health outcomes.
Understanding an ingredient includes looking at its safety evidence, the amount used and the limitations of available studies.
Check the exact ingredient name and composition on a product label. A branded ingredient should not be confused with other substances that have similar names or different chemical structures.
The amount of L-arabinose used in a research study may differ from the quantity in a commercial supplement. Without the actual formulation and dose, research findings cannot be directly applied to a finished product.
Individual responses to food ingredients can vary. Anyone experiencing digestive discomfort after using a new product should stop and seek appropriate advice if symptoms persist.
People with diabetes, impaired glucose regulation or other medical conditions should discuss new supplements with a qualified healthcare professional before use.
Anyone taking medication that affects blood glucose should ask a doctor or pharmacist whether a new ingredient or supplement is appropriate.
A published 28-day toxicology evaluation of Sukré included laboratory and animal testing. This provides useful safety information but does not replace long-term human safety studies.
Early research can help scientists understand how an ingredient interacts with the body. It is important, however, not to extend individual findings beyond what the studies actually measured.
Current research on L-arabinose does not establish that Sukré:
These are different health outcomes that require their own well-designed human studies. Evidence about one mechanism should not be treated as proof of all the others.
Sukré is an interesting ingredient because its identified L-arabinose component has been studied for its interaction with sucrose digestion and short-term blood glucose responses.
Some human studies have reported changes in glucose and insulin responses after consuming L-arabinose with sucrose. Other research highlights that these effects may not carry over to every type of meal or eating pattern.
The most useful approach is to separate the ingredient's identity, its proposed mechanism and the outcomes that have actually been demonstrated. More research is needed before conclusions can be drawn about long-term metabolic benefits, fat storage or the effects of Sukré in finished supplements.
Explore Blood Sugar HealthThis article is intended for general educational and informational purposes only. It does not provide medical advice, diagnosis or treatment and should not replace guidance from a qualified healthcare professional.
Research discussed in this article includes studies of L-arabinose. Findings from these studies should not automatically be interpreted as proof of the effects of every branded ingredient, supplement formulation or commercial product containing a related substance.
People with diabetes, blood glucose concerns, existing medical conditions or those taking medication should consult a qualified healthcare professional before using a supplement intended to influence digestion or blood glucose.
Do not change prescribed medication or treatment based on information in this article.
Explore related topics to understand glucose, insulin and the wider processes involved in metabolic health.
Learn how glucose supplies energy to the body's cells and how the body obtains and uses this important fuel.
Read article →Discover how insulin helps regulate blood glucose and supports the body's use and storage of energy.
Read article →Understand why metabolic health involves more than blood sugar and how everyday habits contribute to overall well-being.
Read article →Explore scientific publications and ingredient information for a closer look at L-arabinose, Sukré and the current evidence.
The ingredient developer's overview of Sukré and its intended use as a prebiotic sweetener in functional food and beverage applications.
Visit Compound Solutions →A 2025 publication evaluating genotoxicity and 28-day oral toxicity of purified L-arabinose from acacia hydrolysate.
Read the PubMed publication →A double-blind randomised crossover study examining how L-arabinose affects glucose absorption after sucrose consumption in healthy adults.
Read the human study →A 2025 randomised crossover trial examining glucose and insulin responses after L-arabinose was added to a sucrose-rich drink.
Read the 2025 study →Research examining whether the effects of L-arabinose on glucose and insulin responses can be reproduced in mixed meals.
Read the study →